Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes
Early detection of prostate cancer (PC) is largely carried out using assessment of prostate-specific antigen (PSA) level; yet it cannot reliably discriminate between benign pathologies and clinically significant forms of PC. To overcome the current limitations of PSA, new urinary and serum biomarker...
Main Authors: | Stefano Salciccia, Anna Laura Capriotti, Aldo Laganà, Stefano Fais, Mariantonia Logozzi, Ettore De Berardinis, Gian Maria Busetto, Giovanni Battista Di Pierro, Gian Piero Ricciuti, Francesco Del Giudice, Alessandro Sciarra, Peter R. Carroll, Matthew R. Cooperberg, Beatrice Sciarra, Martina Maggi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/9/4367 |
Similar Items
-
Androgen-deprivation therapy and SARS-Cov-2 infection: the potential double-face role of testosterone
by: Stefano Salciccia, et al.
Published: (2020-10-01) -
Increased Plasmatic Levels of PSA-Expressing Exosomes Distinguish Prostate Cancer Patients from Benign Prostatic Hyperplasia: A Prospective Study
by: Mariantonia Logozzi, et al.
Published: (2019-09-01) -
Exosomes: A Source for New and Old Biomarkers in Cancer
by: Mariantonia Logozzi, et al.
Published: (2020-09-01) -
Assessment of two-gene urinary test with multiparametric magnetic resonance imaging of the prostate for biopsy naïve men: A prospective study
by: G.M. Busetto, et al.
Published: (2020-10-01) -
Modeling the Contribution of Male Testosterone Levels to the Duration of Positive COVID Testing among Hospitalized Male COVID-19 Patients
by: Stefano Salciccia, et al.
Published: (2021-03-01)